Hjem › Seglcelle-anæmi › Mississippi
Seglcelle-anæmi kliniske forsøg i Mississippi
5 studier for Seglcelle-anæmi søger deltagere på steder i Mississippi.
Byer i Mississippi
Officiel studietekst (engelsk)
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
- Southern Specialty Clinic, Flowood
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07656415A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Southern Specialty Research, Flowood
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06439082A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Southern Specialty Research, Flowood
RekruttererFase 2/3
Alder 12 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT05431088Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Southern Specialty Research, Flowood
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Southern Specialty Research- Site Number : 8400059, Flowood
RekruttererFase 3
Alder 10 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT06975865Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.